Track topics on Twitter Track topics that are important to you
BioVentures, Inc. is committed to the highest levels of scholarship through the submission of original research to peer reviewed publications and presentation of our data at scientific conferences. In the spirit of that cooperation we provide a link to our publications and presentations here, as well as all supplemental data that is required for publication.
1435 Kensington Square Court
United States of America
At the annual Health 2.0 conference in Silicon Valley, a panel of venture capitalists describe areas of health tech that do not appeal to them.
A look at today's forthcoming news stories: GSK has stepped up its drive into emerging markets; an over the counter genetic testing kit is launched in the US, and the head of BioVentures for Global He...
NeuroVia Inc. (small-molecule therapeutics for rare CNS diseases) closed a $14mm Series A round co-led by Novartis Venture Fund and Sanofi-Genzyme BioVentures, which both added members to the company ...
In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Don Joseph, CEO of BioVentures for Global Health about the role of BVGH and their new ...
AnchorDx Corp of Guangzhou raised $28 million in a Series B round to develop precision oncology products using next-generation sequencing technology. The company's major focus applies NGS to methylate...
Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...
BioVentures, Inc. is committed to the highest levels of scholarship through the submission of original research to peer reviewed publications and presentation of our data at scientific conferences. In...
Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing sc...
Headquartered near Research Triangle Park, NC, APR is majority owned and virtually run by Cato BioVentures. APR will work with Advanced Targeting Systems, Cato Research and Cato BioVentures to develop...
HTI was formed in 2004 as a majority-owned portfolio company of Cato BioVentures. Through its strategic development relationship with Cato BioVentures and its contract research and development affilia...
We have published hundreds of BioVentures, Inc. news stories on BioPortfolio along with dozens of BioVentures, Inc. Clinical Trials and PubMed Articles about BioVentures, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioVentures, Inc. Companies in our database. You can also find out about relevant BioVentures, Inc. Drugs and Medications on this site too.